PSMA Avidity in the Heterotropic Ossification-An Incidental Finding on PSMA PET/CT.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
24 Jan 2024
24 Jan 2024
Historique:
medline:
25
1
2024
pubmed:
25
1
2024
entrez:
25
1
2024
Statut:
aheadofprint
Résumé
The upregulations of prostate-specific membrane antigen (PSMA) antigen are used for the presence of prostate cancer. However, published literature shows incidentally detected PSMA uptake in various nonprostatic benign and malignant conditions, which led to questioning the specificity of PSMA-targeted PET. In present case, we highlighted the abnormal PSMA expression in the benign bone abnormality.
Identifiants
pubmed: 38271263
doi: 10.1097/RLU.0000000000005054
pii: 00003072-990000000-00898
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Kirchner MA, Holzgreve A, Brendel M, et al. PSMA PET imaging in glioblastoma: a preclinical evaluation and theranostic outlook. Front Oncol. 2021;11:774017. doi:10.3389/fonc.2021.774017.
doi: 10.3389/fonc.2021.774017
de Galiza Barbosa F, Queiroz MA, Nunes RF, et al. Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging. 2020;20:23. doi:10.1186/s40644-020-00300-7.
doi: 10.1186/s40644-020-00300-7
Meyers C, Lisiecki J, Miller S, et al. Heterotopic ossification: a comprehensive review. JBMR Plus. 2019;3:e10172. doi:10.1002/jbm4.10172.
doi: 10.1002/jbm4.10172
Zychowicz ME. Pathophysiology of heterotopic ossification. Orthop Nurs. 2013;32:173–177; quiz 178-9. doi:10.1097/NOR.0b013e3182920d85.
doi: 10.1097/NOR.0b013e3182920d85
Grünig H, Maurer A, Thali Y, et al. Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging. Eur J Nucl Med Mol Imaging. 2021;48:4483–4494. doi:10.1007/s00259-021-05424-x.
doi: 10.1007/s00259-021-05424-x